{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-018381","form_type":"8-K","ticker":null,"cik":"0001671818","company_name":"Oncorus, Inc.","filed_at":"2023-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.963737+00:00","generated_at":"2026-06-15T16:56:53.086286+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Oncorus gets 180-day Nasdaq extension; stock moves to Capital Market","bullets":["Nasdaq granted extension until October 30, 2023 to meet $1.00 minimum bid price rule.","Oncorus common stock transferred from Nasdaq Global Market to Capital Market effective May 3, 2023.","To regain compliance, closing bid price must be $1.00+ for 10 consecutive business days.","Company may consider reverse stock split; failure could lead to delisting and appeal process.","CEO Ted Ashburn signed the filing; no assurance of regaining compliance stated."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-018381","json":"https://secwatch.observer/filing/0000950170-23-018381.json","markdown":"https://secwatch.observer/filing/0000950170-23-018381.md","text":"https://secwatch.observer/filing/0000950170-23-018381.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671818/000095017023018381/0000950170-23-018381-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671818/000095017023018381/oncr-20230502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T16:56:53.086286+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f3230150f8d50c61ee02de8bb03239eeadc60406","claim":"Oncorus, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"May 2, 2023, Oncorus, Inc. (the “ Company ”) received a notice (the “ Extension Notice ”) from the Listing Qualifications Department of the Nasdaq Stock Market (“ Nasdaq ”) informing the Company that Nasdaq granted the Company an additional 180 calendar days, or until October 30, 2023, to regain compliance with the minimum closing bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “ Rule ”). In connection with the Extension Notice, the listing of the Company’s common stock was transferred from the Nasdaq Global Market to the Nasda","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1671818/000095017023018381/0000950170-23-018381-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"extension granted"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}